StonvexLoading…
StonvexStonvexStonvexCore line items from HPK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $863.36M | $1.12B | $1.13B | $755.69M |
Operating Income | $149.98M | $337.41M | $426.46M | $422.56M |
Net Income | $18.96M | $95.07M | $215.87M | $236.85M |
EPS (Diluted) | $0.14 | $0.67 | $1.58 | $1.93 |
Total Assets | $3.21B | $3.06B | $3.08B | $2.28B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $162.07M | $86.65M | $194.51M | $30.50M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 125.33M | 126.07M | 128.42M | 113.17M |